Skip to main content Accessibility help
×
×
Home

The application of probiotic fermented milks in cancer and intestinal inflammation

  • Alejandra de Moreno de LeBlanc (a1) and Gabriela Perdigón (a1) (a2)
Abstract

Lactic acid bacteria are present in many foods such as yoghurt and are frequently used as probiotics to improve some biological functions of the host. Many researchers have evaluated the effects of yoghurt and lactic acid bacteria against diseases such as cancer and intestinal inflammation. The preventive effect of probiotics on intestinal carcinogenesis may be associated with changes in the intestinal microbiota, suppressing the growth of bacteria that convert procarcinogens into carcinogens. Other mechanisms could be related to the immune response modulation and have been evaluated using milks fermented with lactic acid bacteria in chemically induced colon cancer and hormone-dependent breast cancer models. We demonstrated, using a murine colon cancer model, that yoghurt consumption inhibited tumour growth by decreasing the inflammatory response by increasing IL-10-secreting cells, cellular apoptosis and diminishing procarcinogenic enzymes. Milk fermented with Lactobacillus helveticus R389 delayed breast tumour growth by decreasing IL-6 and increasing IL-10 in serum and in the mammary glands and tumour-infiltrating immune cells. Previous results obtained with yoghurt administration in a colon cancer model led us to analyse its effect on a trinitrobenzenesulfonic acid-induced intestinal inflammation model in mice. Yoghurt was able to attenuate the symptoms of acute inflammation by reducing inflammatory cytokines, and increasing regulatory cytokine IL-10-producing cells, leading to desirable changes of the intestinal microbiota. It was demonstrated, by using murine models, that the consumption of fermented milks can modulate the immune system and can maintain it in a state of surveillance, which could affront different pathologies such as cancer and intestinal inflammation.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The application of probiotic fermented milks in cancer and intestinal inflammation
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The application of probiotic fermented milks in cancer and intestinal inflammation
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The application of probiotic fermented milks in cancer and intestinal inflammation
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Gabriela Perdigón, fax 54 381 4005600, email perdigon@cerela.org.ar
References
Hide All
1.Codex Alimentarius (2003) Codex standard for fermented milks. CODEX STAN 243-2003. http://www.codexalimentarius.net/web/standard_list.do.
2.Perdigon, G, Fuller, R & Raya, R (2001) Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2, 2742.
3.Kato, I (2000) Antitumor activity of lactic acid bacteria. In Probiotics 3: Immunomodulation by the Gut Microflora and Probiotics, pp. 115138 [Fuller, R & Perdigon, G]. London: Kluwer Academic Publishers.
4.de Moreno de Leblanc, A & Perdigon, G (2004) Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Med Sci Monit 10, BR96–BR104.
5.Matar, C, Valdez, JC, Medina, M et al. (2001) Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J Dairy Res 68, 601609.
6.Kato, I, Yokokura, T & Mutai, M (1984) Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. Microbiol Immunol 28, 209217.
7.Hayashi, K & Ohwaki, M (1989) Antitumoor activity of Lactobacillus casei (LC 9018) in mice: T cell subset depletion. Biotherapy 3, 15681574.
8.de Moreno de LeBlanc, A & Perdigon, G (2005) Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell 29, 1524.
9.de Moreno de LeBlanc, A, Valdez, J & Perdigón, G (2004) Inflammatory immune response. Eur J Inflamm 2, 2131.
10.Bogdan, C, Rollinghoff, M & Diefenbach, A (2000) The role of nitric oxide in innate immunity. Immunol Rev 173, 1726.
11.Patton, EA, La Flamme, AC, Pedras-Vasoncelos, JA et al. (2002) Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasis. Infect Immun 70, 177184.
12.Perdigon, G, de Moreno de LeBlanc, A, Valdez, J et al. (2002) Role of yoghurt in the prevention of colon cancer. Eur J Clin Nutr 56, Suppl. 3, S65S68.
13.Langholz, E, Munkholm, P, Davidsen, M et al. (1992) Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103, 14441451.
14.Gillen, CD, Walmsley, RS, Prior, P et al. (1994) Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35, 15901592.
15.Linskens, RK, Huijsdens, XW, Savelkoul, PH et al. (2001) The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 36, 2940.
16.de Moreno de LeBlanc, A, Chaves, S & Perdigón, G (2009) Effect of yoghurt on the cytokine profile using a murine model of intestinal inflammation. Eur J Inflamm 7, 97–109.
17.Rath, HC, Wilson, KH & Sartor, RB (1999) Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 67, 29692974.
18.Verdu, EF, Bercik, P, Cukrowska, B et al. (2000) Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice. Clin Exp Immunol 120, 4650.
19.Chandran, P, Satthaporn, S, Robins, A et al. (2003) Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). Surgeon 1, 6375.
20.Videla, S, Vilaseca, J, Guarner, F et al. (1994) Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut 35, 10901097.
21.Favier, C, Neut, C, Mizon, C et al. (1997) Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 42, 817822.
22.Malin, M, Suomalainen, H, Saxelin, M et al. (1996) Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 40, 137145.
23.de Moreno de LeBlanc, A, Matar, C & Perdigon, G (2007) The application of probiotics in cancer. Br J Nutr 98, Suppl. 1, S105S110.
24.Fuss, IJ, Neurath, M, Boirivant, M et al. (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157, 12611270.
25.Dong, C (2006) Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 6, 329333.
26.Zhang, Z, Zheng, M, Bindas, J et al. (2006) Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 12, 382388.
27.Berg, DJ, Davidson, N, Kuhn, R et al. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98, 10101020.
28.Singh, B, Read, S, Asseman, C et al. (2001) Control of intestinal inflammation by regulatory T cells. Immunol Rev 182, 190200.
29.Brandtzaeg, P, Farstad, IN & Haraldsen, G (1999) Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol Today 20, 267277.
30.Brandtzaeg, P & Pabst, R (2004) Let's go mucosal: communication on slippery ground. Trends Immunol 25, 570577.
31.de Moreno de LeBlanc, A, Maldonado Galdeano, C, Chaves, S et al. (2005) Oral administration of Lactobacillus casei CRL 431 increases immunity in bronchus and mammary glands. Eur J Inflamm 3, 2328.
32.LeBlanc, JG, Matar, C, Valdez, JC et al. (2002) Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J Dairy Sci 85, 27332742.
33.Vinderola, CG, Duarte, J, Thangavel, D et al. (2005) Immunomodulating capacity of kefir. J Dairy Res 72, 195202.
34.Furukawa, N, Matsuoka, A, Takahashi, T et al. (1990) Effects of orally administered yogurt and kefir on tumor growth in mice. J Jpn Soc Nutr Food Sci 43, 450453.
35.Murofushi, M, Mizuguchi, J, Aibara, K et al. (1986) Immunopotentiative effect of polysaccharide from kefir grain, KGF-C, administered orally in mice. Immunopharmacology 12, 2935.
36.de Moreno de LeBlanc, A, Matar, C, Farnworth, E et al. (2006) Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine 34, 18.
37.Reome, JB, Hylind, JC, Dutton, RW et al. (2004) Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. Clin Immunol 111, 6981.
38.Zhang, G, Li, W, Holle, L et al. (2002) A novel design of targeted endocrine and cytokine therapy for breast cancer. Clin Cancer Res 8, 11961205.
39.Reed, MJ & Purohit, A (1997) Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 18, 701715.
40.de Moreno de LeBlanc, A, Matar, C, LeBlanc, N et al. (2005) Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res 7, 477486.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed